Journey Medical Corp - Common Stock (DERM)

CUSIP: 48115J109

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock
Shares outstanding
21,352,124
Total 13F shares
1,668,350
Share change
-114,012
Total reported value
$2,620,320
Price per share
$1.57
Number of holders
16
Value change
-$179,207
Number of buys
4
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 48115J109?
CUSIP 48115J109 identifies DERM - Journey Medical Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Fortress Biotech, Inc.
3/4/5
10%+ Owner
class O/S missing
3,860,467
$11,735,820 12 May 2022
B. Riley Securities, Inc.
13F
Company
4%
864,695
$1,660,214 31 Dec 2022
13F
BRC Group Holdings, Inc.
13F
Company
4%
864,695
$1,660,214 31 Dec 2022
13F
Ernest Robert de Paolantonio
3/4/5
Officer
class O/S missing
259,907
$1,356,715 04 Oct 2022
PERKINS CAPITAL MANAGEMENT INC
13F
Company
1.1%
225,800
$434,000 31 Dec 2022
13F
Nantahala Capital Management, LLC
13F
Company
1.1%
225,996
$433,912 31 Dec 2022
13F
AMERICAN FINANCIAL GROUP INC
13F
Company
0.84%
180,000
$346,000 31 Dec 2022
13F
Neuberger Berman Group LLC
13F
Company
0.62%
132,421
$254,248 31 Dec 2022
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.17%
35,294
$67,764 31 Dec 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
29,932
$57,000 31 Dec 2022
13F
Cerity Partners LLC
13F
Company
0.12%
25,421
$48,808 31 Dec 2022
13F
B. Riley Wealth Advisors, Inc.
13F
Company
0.08%
17,250
$33,120 31 Dec 2022
13F
VANGUARD GROUP INC
13F
Company
0.08%
16,949
$32,542 31 Dec 2022
13F
Wealth Alliance Advisory Group, LLC
13F
Company
0.08%
16,124
$30,958 31 Dec 2022
13F
Creative Planning
13F
Company
0.06%
11,764
$22,587 31 Dec 2022
13F
Allegiance Financial Group Advisory Services LLC
13F
Company
0.05%
10,000
$19,200 31 Dec 2022
13F
BlackRock Finance, Inc.
13F
Company
0.04%
8,446
$16,216 31 Dec 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.04%
7,633
$15,000 31 Dec 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
44
$84 31 Dec 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
14
$26 31 Dec 2022
13F

Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q1 2023

As of 31 Mar 2023, Journey Medical Corp - Common Stock (DERM) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,668,350 shares. The largest 10 holders included B. Riley Financial, Inc., PERKINS CAPITAL MANAGEMENT INC, Nantahala Capital Management, LLC, AMERICAN FINANCIAL GROUP INC, Neuberger Berman Group LLC, FIRST MANHATTAN CO. LLC., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, B. Riley Wealth Advisors, Inc., and Creative Planning. This page lists 16 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders
18
Q1 2023 holders
16
Holder diff
-2
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 Value $ Q1 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .